Brownstein and his team noted that women and adults aged 66 to 75 saw the largest decreases in obesity. People living in the ...

But weight loss alone does not explain the drugs’ benefits. Both Holst and Sattar pointed to a discontinued GLP-1 drug once ...

Elon Musk, the richest person alive and the co-head of President-elect Donald Trump’s new Department of Government Efficiency ...

Obesity is down in the US for the first time in a decade. A new study suggests weight-loss drugs may explain why.

The high list prices of these new weight loss drugs are costly for taxpayer-funded ... Zepbound and Mounjaro have been in ...

Despite this escalating demand for popular GLP-1 drugs, the prices for some of these products are actually dropping. Dr.

Thanks to effective and popular new drugs for weight loss and diabetes – an estimated 1 in 8 adults in the US has used ...

More than one in four UK adults are obese, but only a small number will be eligible for the latest treatment from the NHS ...

People taking new weight-loss drugs say they curb cravings for booze, drugs, and nicotine. Did scientists inadvertently ...

Pharmaceutical giants Eli Lilly and Company & Novo Nordisk A/S face challenges in the obesity market despite promising data.

A new study found bariatric surgeries have recently dropped as the popularity of weight-loss drugs like Wegovy and ... obesity and determined that between 2022 and 2023, rates of bariatric ...